SIGA Technologies, Inc. (NASDAQ:SIGA – Get Free Report) saw unusually large options trading on Wednesday. Traders acquired 1,200 call options on the company. This is an increase of 1,438% compared to the average daily volume of 78 call options.
Institutional Trading of SIGA Technologies
Several hedge funds and other institutional investors have recently made changes to their positions in SIGA. Bank of New York Mellon Corp raised its holdings in SIGA Technologies by 8.8% during the second quarter. Bank of New York Mellon Corp now owns 194,817 shares of the company’s stock worth $1,479,000 after purchasing an additional 15,765 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of SIGA Technologies by 38.9% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,684 shares of the company’s stock worth $104,000 after buying an additional 3,829 shares in the last quarter. Rhumbline Advisers lifted its holdings in shares of SIGA Technologies by 4.2% in the 2nd quarter. Rhumbline Advisers now owns 69,947 shares of the company’s stock valued at $531,000 after buying an additional 2,851 shares during the period. Victory Capital Management Inc. boosted its stake in shares of SIGA Technologies by 39.2% in the second quarter. Victory Capital Management Inc. now owns 244,857 shares of the company’s stock valued at $1,858,000 after buying an additional 69,006 shares in the last quarter. Finally, LSV Asset Management purchased a new stake in shares of SIGA Technologies in the second quarter valued at approximately $807,000. Hedge funds and other institutional investors own 55.40% of the company’s stock.
SIGA Technologies Trading Down 0.2 %
Shares of SIGA stock opened at $6.28 on Thursday. The company has a market capitalization of $448.42 million, a P/E ratio of 5.23 and a beta of 0.94. The business’s 50 day moving average is $6.57 and its two-hundred day moving average is $7.63. SIGA Technologies has a twelve month low of $4.26 and a twelve month high of $12.83.
SIGA Technologies Company Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Featured Stories
- Five stocks we like better than SIGA Technologies
- Election Stocks: How Elections Affect the Stock Market
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.